Pharmaceutical Technology

DECEMBER 5, 2022

CB1 receptors are primarily expressed in the brain and central nervous system, whereas CB2 receptors are expressed in T-cells in the immune system. Figure 1 shows the targets in preclinical trials for central nervous system diseases, as sourced from GlobalData’s Drugs Database.

Medical 98

Medical Specialization Marketing Leads 98

Pharmaceutical Technology

MAY 19, 2023

Multiple sclerosis (MS) is a primary autoimmune disease in which inflammation is a core contributor to the degeneration of the central nervous system (CNS), leading to neurological disability and affecting sensory, visual, motor, and autonomic systems. DMTs for MS have a high price tag, particularly in the US.

Prospecting 98

Prospecting Marketing Patients Leads 98

Pharmaceutical Technology

MAY 15, 2023

Innovation S-curve for the pharmaceutical industry Peptide nano-particle conjugates is a key innovation area in the pharmaceutical industry By tagging peptides with nanoparticles, peptide nano-particle conjugates allow enhanced control over their biological behaviour, overcoming intrinsic limitations of the individual materials.

Pharmaceutical 52

Pharmaceutical Leads Biopharma Medicine 52

European Pharmaceutical Review

DECEMBER 27, 2023

production and delivery of CAR T cells necessitates close collaboration between the pharma industry and academic departments CAR T production slots are assigned based on availability and a periodic quota system per referring institution or geographic location. This is in addition to its considerable price tag. Leukemia & Lymphoma.

Manufacturing 83

Manufacturing Food and Drug Administration Patients Pharma 83